{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T12:20:06Z","timestamp":1789474806657,"version":"build-2803163510"},"reference-count":56,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:00:00Z","timestamp":1770940800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,27]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Antithrombotic therapy (AT) is crucial for preventing life-threatening thromboembolic events (TEEs). However, concerns about bleeding events (BEs) often lead to AT discontinuation before image-guided breast biopsy (iBB). This systematic review and meta-analysis assess the necessity and safety of AT suspension prior to iBB.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A systematic review was conducted using Embase and PubMed\/MEDLINE databases through July 2024. Studies evaluating BEs in patients who had AT and were undergoing iBB were included. Case reports, surveys, and nonretrievable full texts were excluded. Data analysis was performed using Review Manager v5.4. The risk-of-bias assessment was based on the Risk Of Bias in Non-randomized Studies of Interventions tool.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of the 216 studies screened, 8 met the inclusion criteria, which comprised 1154 patients undergoing AT and 10 370 controls. Bleeding events occurred in 203 (17.9%) patients with AT and 1110 (10.7%) controls, yielding a pooled odds ratio of 1.89 (Z = 5.23; P &amp;lt; 0.001). Heterogeneity was moderate (I\u00b2 = 34%). Variability existed in AT drugs, iBB techniques, and definitions of \u201cclinically relevant BE.\u201d Only 3 (0.23%) BEs were considered \u201cclinically relevant\u201d in 1 study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Although current evidence is burdened by unstandardized reporting and data fragmentation, it supports the safety of performing iBB without suspending ongoing AT because local BEs, although slightly more frequent under AT, are predominantly minor and clinically irrelevant. Antithrombotic therapy continuation can improve diagnostic efficiency, minimize delays, limit patient anxiety, and reduce health care costs. Our quantitative findings support AT continuation in the context of iBB while providing a clinical rationale that addresses the TEE risks associated with AT interruption\u2014an issue often underrepresented in prior literature.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/jbi\/wbaf062","type":"journal-article","created":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T11:43:29Z","timestamp":1758627809000},"page":"136-148","source":"Crossref","is-referenced-by-count":1,"title":["The Management of Antithrombotic Therapy in Image-Guided Breast Biopsy: A Systematic Review With Meta-Analysis"],"prefix":"10.1093","volume":"8","author":[{"given":"Mario","family":"Villani","sequence":"first","affiliation":[{"name":"Department of Breast Imaging, Gentofte Hospital , Hellerup (Copenhagen) ,","place":["Denmark"]},{"name":"Department of Breast Radiology, Central Hospital Karlstad , Karlstad ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2051-5442","authenticated-orcid":false,"given":"Fabio","family":"Zecca","sequence":"additional","affiliation":[{"name":"Department of Breast Imaging, Gentofte Hospital , Hellerup (Copenhagen) ,","place":["Denmark"]},{"name":"Department of Medical Imaging, University Cancer Institute of Toulouse\u2013Oncopole , Toulouse ,","place":["France"]},{"name":"Department of Radiology, University Hospital of Cagliari , Monserrato ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Falko","family":"Ensle","sequence":"additional","affiliation":[{"name":"Institute of Diagnostic and Interventional Radiology, University Hospital Zurich , Zurich ,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2078-4730","authenticated-orcid":false,"given":"Lisa","family":"Jungblut","sequence":"additional","affiliation":[{"name":"Institute of Diagnostic and Interventional Radiology, University Hospital Zurich , Zurich ,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Athanasiou","sequence":"additional","affiliation":[{"name":"Department of Breast Imaging, Mitera Hospital , Marousi ,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9r\u00e9nice","family":"Boulet","sequence":"additional","affiliation":[{"name":"Department of Medical Imaging, University Cancer Institute of Toulouse\u2013Oncopole , Toulouse ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilse","family":"Vejborg","sequence":"additional","affiliation":[{"name":"Department of Breast Imaging, Gentofte Hospital , Hellerup (Copenhagen) ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,2,13]]},"reference":[{"issue":"4","key":"2026032712531121200_wbaf062-B1","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.2214\/AJR.07.3537","article-title":"Anticoagulation and bleeding risk after core needle biopsy","volume":"191","author":"Somerville","year":"2008","journal-title":"AJR Am J Roentgenol"},{"issue":"1","key":"2026032712531121200_wbaf062-B2","doi-asserted-by":"publisher","first-page":"E18","DOI":"10.1188\/18.CJON.E18-E22","article-title":"Antithrombotic therapy: evaluation of the safety of performing core needle biopsy of the breast without suspending medication","volume":"22","author":"Cameron","year":"2018","journal-title":"Clin J Oncol Nurs"},{"issue":"1","key":"2026032712531121200_wbaf062-B3","doi-asserted-by":"publisher","first-page":"245","DOI":"10.2214\/ajr.174.1.1740245","article-title":"Core needle breast biopsy in patients undergoing anticoagulation therapy: preliminary results","volume":"174","author":"Melotti","year":"2000","journal-title":"AJR Am J Roentgenol"},{"issue":"4","key":"2026032712531121200_wbaf062-B4","doi-asserted-by":"publisher","first-page":"438","DOI":"10.2214\/AJR.23.29164","article-title":"Bleeding events after image-guided breast biopsies: comparison of patients temporarily discontinuing versus maintaining antithrombotic therapy during biopsy","volume":"221","author":"Reichman","year":"2023","journal-title":"AJR Am J Roentgenol"},{"issue":"1","key":"2026032712531121200_wbaf062-B5","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13244-019-0803-x","article-title":"European Society of Breast Imaging (EUSOBI), with language review by Europa Donna\u2013The European Breast Cancer Coalition. Image-guided breast biopsy and localisation: recommendations for information to women and referring physicians by the European Society of Breast Imaging","volume":"11","author":"Bick","year":"2020","journal-title":"Insights Imaging"},{"key":"2026032712531121200_wbaf062-B6","author":"American College of Radiology"},{"issue":"8","key":"2026032712531121200_wbaf062-B7","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1016\/j.jvir.2019.04.017","article-title":"Society of Interventional Radiology consensus guidelines for the periprocedural management of thrombotic and bleeding risk in patients undergoing percutaneous image-guided interventions\u2014part ii: recommendations","volume":"30","author":"Patel","year":"2019","journal-title":"J Vasc Interv Radiol"},{"issue":"Suppl 1","key":"2026032712531121200_wbaf062-B8","first-page":"116","article-title":"Guidelines on radiologically-guided percutaneous biopsy\/excision of breast lesions in patients receiving oral anticoagulants -old and new","volume":"19","author":"Papantoniou","year":"2017","journal-title":"Breast Cancer Res"},{"issue":"2","key":"2026032712531121200_wbaf062-B9","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1159\/000536079","article-title":"Management of patients with breast biopsy under anti-coagulation or anti-platelet therapy: results of a survey of German experts","volume":"19","author":"Riedel","year":"2024","journal-title":"Breast Care"},{"issue":"1","key":"2026032712531121200_wbaf062-B10","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1148\/radiol.221871","article-title":"Breast biopsy and hematoma associated with antithrombotic therapy","volume":"306","author":"Chang","year":"2023","journal-title":"Radiology"},{"issue":"1","key":"2026032712531121200_wbaf062-B11","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1002\/ijc.28671","article-title":"Anticoagulant medication at time of needle biopsy for breast cancer in relation to risk of lymph node metastasis","volume":"135","author":"Ljung","year":"2014","journal-title":"Int J Cancer"},{"issue":"3","key":"2026032712531121200_wbaf062-B12","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1080\/02841850701784552","article-title":"Hematoma after vacuum-assisted breast biopsy: a preventable condition?","volume":"49","author":"Zografos","year":"2008","journal-title":"Acta Radiol"},{"issue":"4","key":"2026032712531121200_wbaf062-B13","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1093\/jbi\/wbad040","article-title":"Current practices in anticoagulation management for patients undergoing percutaneous image-guided breast procedures","volume":"5","author":"Brown","year":"2023","journal-title":"J Breast Imaging"},{"key":"2026032712531121200_wbaf062-B14","doi-asserted-by":"publisher","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"issue":"3","key":"2026032712531121200_wbaf062-B15","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.crad.2007.09.006","article-title":"Management of patients taking antiplatelet or anticoagulant medication requiring invasive breast procedures: United Kingdom survey of radiologists\u2019 and surgeons\u2019 current practice","volume":"63","author":"Pritchard","year":"2008","journal-title":"Clin Radiol"},{"issue":"4","key":"2026032712531121200_wbaf062-B16","doi-asserted-by":"publisher","first-page":"448","DOI":"10.2214\/AJR.23.29626","article-title":"Editorial comment: temporary withholding of antithrombotic therapy before a core needle breast or axillary biopsy does not reduce the risk of postbiopsy hematoma","volume":"221","author":"Perry","year":"2023","journal-title":"AJR Am J Roentgenol"},{"issue":"3","key":"2026032712531121200_wbaf062-B17","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.jradnu.2023.06.009","article-title":"Antithrombotic Therapy and core needle breast biopsy: a question of temporary discontinuance or maintaining","volume":"42","author":"Gruzalski","year":"2023","journal-title":"J Radiol Nurs"},{"issue":"3","key":"2026032712531121200_wbaf062-B18","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1093\/jbi\/wbac020","article-title":"Bleeding complications after breast core-needle biopsy - an approach to managing patients on antithrombotic therapy","volume":"4","author":"Goudreau","year":"2022","journal-title":"J Breast Imaging"},{"key":"2026032712531121200_wbaf062-B19","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.clinimag.2020.09.014","article-title":"Bleeding risk after percutaneous breast needle biopsy in patients on anticoagulation therapy","volume":"70","author":"McMahon","year":"2021","journal-title":"Clin Imaging"},{"issue":"1","key":"2026032712531121200_wbaf062-B20","doi-asserted-by":"crossref","first-page":"9","DOI":"10.37549\/AR1864","article-title":"Breast biopsy: anesthesia, bleeding prevention, representative sampling, and rad\/path concordance","volume":"41","author":"Flowers","year":"2012","journal-title":"Appl Radiol"},{"issue":"5","key":"2026032712531121200_wbaf062-B21","article-title":"Complication rates after performing core needle breast biopsy in women taking anticoagulants versus women not taking anticoagulants: preliminary results from a prospective study","volume":"198","author":"Chetlen","year":"2012","journal-title":"AJR Am J Roentgenol"},{"issue":"7","key":"2026032712531121200_wbaf062-B22","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1159\/000219366","article-title":"Hematoma after vacuum-assisted breast biopsy: are interleukins predictors?","volume":"32","author":"Zografos","year":"2009","journal-title":"Onkologie"},{"key":"2026032712531121200_wbaf062-B23","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/1756-0500-3-70","article-title":"Volume of blood suctioned during vacuum-assisted breast biopsy predicts later hematoma formation","volume":"3","author":"Zagouri","year":"2010","journal-title":"BMC Res Notes"},{"issue":"1","key":"2026032712531121200_wbaf062-B24","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1186\/s12913-019-4669-x","article-title":"Cost of incorrect application of antithrombotic prophylaxis prior to invasive procedures","volume":"19","author":"Cuevas","year":"2019","journal-title":"BMC Health Serv Res"},{"issue":"5","key":"2026032712531121200_wbaf062-B25","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.21037\/gs-20-344","article-title":"Prediction of postoperative hematoma occurrence after ultrasound-guided vacuum-assisted breast biopsy in minimally invasive surgery for percutaneous removal of benign breast lesions","volume":"9","author":"Zheng","year":"2020","journal-title":"Gland Surg"},{"key":"2026032712531121200_wbaf062-B26","doi-asserted-by":"publisher","first-page":"110017","DOI":"10.1016\/j.clinimag.2023.110017","article-title":"Clinically significant bleeding complications of percutaneous breast biopsy: 10-year analysis and a proposed management algorithm","volume":"104","author":"Lewis","year":"2023","journal-title":"Clin Imaging"},{"issue":"Suppl 7","key":"2026032712531121200_wbaf062-B27","first-page":"706","article-title":"Breast surgery and biopsy in anticoagulated patients","volume":"70","author":"Uehara","year":"2012","journal-title":"Nihon Rinsho"},{"key":"2026032712531121200_wbaf062-B28","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1111\/hae.14715","article-title":"Minor procedures in patients with congenital bleeding disorders - one centre experience","volume":"29","author":"Bernardino","year":"2023","journal-title":"Haemophilia"},{"issue":"1","key":"2026032712531121200_wbaf062-B29","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S1001-9294(16)30019-0","article-title":"Percutaneous removal of benign breast lesions with an ultrasound-guided vacuum-assisted system: influence factors in the hematoma formation","volume":"31","author":"Huo","year":"2016","journal-title":"Chin Med Sci J"},{"issue":"1","key":"2026032712531121200_wbaf062-B30","doi-asserted-by":"publisher","first-page":"215","DOI":"10.2214\/AJR.12.9930","article-title":"Hematoma formation during breast core needle biopsy in women taking antithrombotic therapy","volume":"201","author":"Chetlen","year":"2013","journal-title":"AJR Am J Roentgenol"},{"issue":"6","key":"2026032712531121200_wbaf062-B31","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1177\/2045125315612014","article-title":"Serotonergic antidepressants and increased bleeding risk in patients undergoing breast biopsy","volume":"5","author":"Mahdanian","year":"2015","journal-title":"Ther Adv Psychopharmacol"},{"key":"2026032712531121200_wbaf062-B32","doi-asserted-by":"publisher","first-page":"9634938","DOI":"10.1155\/2021\/9634938","article-title":"Preprocedural hypertension is not a risk factor for postoperative bleeding following image-guided core needle breast biopsy","volume":"2021","author":"Salastekar","year":"2021","journal-title":"Radiol Res Pract"},{"issue":"1","key":"2026032712531121200_wbaf062-B33","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1148\/radiol.220548","article-title":"Antithrombotic therapy and hematoma risk during image-guided core-needle breast biopsy","volume":"306","author":"Loving","year":"2023","journal-title":"Radiology"},{"key":"2026032712531121200_wbaf062-B34","volume-title":"ACR\u00ae BI-RADS Atlas, Breast Imaging Reporting and Data System","author":"D\u2019Orsi","year":"2013","edition":"5th ed"},{"key":"2026032712531121200_wbaf062-B35","author":"National Health Service"},{"issue":"4","key":"2026032712531121200_wbaf062-B36","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.clbc.2023.12.008","article-title":"Updates in the surgical management of benign and high-risk breast lesions","volume":"24","author":"Marin","year":"2024","journal-title":"Clin Breast Cancer"},{"key":"2026032712531121200_wbaf062-B37","author":"Soci\u00e9t\u00e9 d\u2019Imagerie de la Femme"},{"issue":"9","key":"2026032712531121200_wbaf062-B38","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1161\/STROKEAHA.110.611905","article-title":"Withdrawal of antithrombotic agents and its impact on ischemic stroke occurrence","volume":"42","author":"Broderick","year":"2011","journal-title":"Stroke"},{"issue":"4","key":"2026032712531121200_wbaf062-B39","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1016\/j.jstrokecerebrovasdis.2016.01.006","article-title":"Withdrawal of antithrombotic agents and the risk of stroke","volume":"25","author":"Wagner","year":"2016","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"4","key":"2026032712531121200_wbaf062-B40","doi-asserted-by":"publisher","first-page":"E7","DOI":"10.3171\/2023.7.FOCUS23341","article-title":"Stroke risk related to intentional discontinuation of antithrombotic therapy for invasive procedures","volume":"55","author":"Mitsui","year":"2023","journal-title":"Neurosurg Focus"},{"issue":"11","key":"2026032712531121200_wbaf062-B41","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1001\/jamainternmed.2019.2431","article-title":"Perioperative management of patients with atrial fibrillation receiving a direct oral anticoagulant","volume":"179","author":"Douketis","year":"2019","journal-title":"JAMA Intern Med"},{"issue":"9","key":"2026032712531121200_wbaf062-B42","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1056\/NEJMoa1501035","article-title":"Perioperative bridging anticoagulation in patients with atrial fibrillation","volume":"373","author":"Douketis","year":"2015","journal-title":"N Engl J Med"},{"issue":"13","key":"2026032712531121200_wbaf062-B43","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1161\/CIRCULATIONAHA.117.028321","article-title":"Low-dose aspirin discontinuation and risk of cardiovascular events: a Swedish nationwide, population-based cohort study","volume":"136","author":"Sundstr\u00f6m","year":"2017","journal-title":"Circulation"},{"issue":"6","key":"2026032712531121200_wbaf062-B44","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.jacc.2012.09.057","article-title":"Outcomes of discontinuing rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: analysis from the ROCKET AF trial (Rivaroxaban once-daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation)","volume":"61","author":"Patel","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"2026032712531121200_wbaf062-B45","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1185\/030079906X89801","article-title":"Review of the rebound phenomenon in new anticoagulant treatments","volume":"22","author":"Hermans","year":"2006","journal-title":"Curr Med Res Opin"},{"issue":"2","key":"2026032712531121200_wbaf062-B46","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1046\/j.1365-2141.1996.d01-1499.x","article-title":"Rebound after cessation of oral anticoagulant therapy: the biochemical evidence","volume":"92","author":"Genewein","year":"1996","journal-title":"Br J Haematol"},{"key":"2026032712531121200_wbaf062-B47","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ijcard.2018.04.123","article-title":"Rebound\u201d hypercoagulability after interruption of anticoagulation in patients with atrial fibrillation","volume":"271","author":"Li","year":"2018","journal-title":"Int J Cardiol"},{"issue":"6","key":"2026032712531121200_wbaf062-B48","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1093\/jbi\/wbad090","article-title":"Severe adverse event related to holding antithrombotic therapy before breast biopsy","volume":"6","author":"Garrett","year":"2024","journal-title":"J Breast Imaging"},{"issue":"2","key":"2026032712531121200_wbaf062-B49","first-page":"170","article-title":"Heparin resistance and coagulation activation rebound effect after anticoagulant withdrawal: beneficiary effect of adjuvant antiplatelet therapy","volume":"35","author":"Gionis","year":"2016","journal-title":"Int Angiol"},{"issue":"11","key":"2026032712531121200_wbaf062-B50","first-page":"258","article-title":"Clinical evidence for rebound hypercoagulability after discontinuing oral anticoagulants for venous thromboembolism","volume":"10","author":"Cundiff","year":"2008","journal-title":"Medscape J Med"},{"key":"2026032712531121200_wbaf062-B51","doi-asserted-by":"publisher","first-page":"m4087","DOI":"10.1136\/bmj.m4087","article-title":"Mortality due to cancer treatment delay: systematic review and meta-analysis","volume":"4","author":"Hanna","year":"2020","journal-title":"BMJ"},{"issue":"5","key":"2026032712531121200_wbaf062-B52","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1177\/1359105315607828","article-title":"Anxiety prior to breast biopsy: relationships with length of time from breast biopsy recommendation to biopsy procedure and psychosocial factors","volume":"22","author":"Hayes Balmadrid","year":"2017","journal-title":"J Health Psychol"},{"issue":"5","key":"2026032712531121200_wbaf062-B53","doi-asserted-by":"publisher","first-page":"e739","DOI":"10.1016\/J.EJRAD.2012.01.033","article-title":"Interventional bleeding, hematoma and scar-formation after vacuum-biopsy under stereotactic guidance: Mammotome(\u00ae)-system 11 g\/8 g vs. ATEC(\u00ae)-system 12 g\/9 g","volume":"81","author":"Schaefer","year":"2012","journal-title":"Eur J Radiol"},{"issue":"2","key":"2026032712531121200_wbaf062-B54","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1148\/RADIOLOGY.193.2.7972743","article-title":"Percutaneous large-core breast biopsy: a multi-institutional study","volume":"193","author":"Parker","year":"1994","journal-title":"Radiology"},{"issue":"5","key":"2026032712531121200_wbaf062-B55","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1097\/JS9.0000000000000257","article-title":"The comparison of efficacy and safety evaluation of vacuum-assisted Elite 10-G system and the traditional BARD 14-G core needle in breast diagnosis: an open-label, parallel, randomized controlled trial","volume":"109","author":"Zhang","year":"2023","journal-title":"Int J Surg"},{"issue":"2","key":"2026032712531121200_wbaf062-B56","doi-asserted-by":"publisher","first-page":"157","DOI":"10.3348\/KJR.2023.0874","article-title":"Hemorrhagic complications following ultrasound-guided breast biopsy: a prospective patient-centered study","volume":"25","author":"Yoen","year":"2024","journal-title":"Korean J Radiol"}],"container-title":["Journal of Breast Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jbi\/article-pdf\/8\/2\/136\/66892546\/wbaf062.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbi\/article-pdf\/8\/2\/136\/66892546\/wbaf062.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T16:53:17Z","timestamp":1774630397000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbi\/article\/8\/2\/136\/8482883"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,13]]},"references-count":56,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2,13]]},"published-print":{"date-parts":[[2026,3,27]]}},"URL":"https:\/\/doi.org\/10.1093\/jbi\/wbaf062","relation":{},"ISSN":["2631-6110","2631-6129"],"issn-type":[{"value":"2631-6110","type":"print"},{"value":"2631-6129","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,3]]},"published":{"date-parts":[[2026,2,13]]}}}